The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer

This article has been retracted at the request of the authors. Retraction: The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer

[1]  Stephen M Hewitt,et al.  Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. , 2008, Cancer research.

[2]  Debra L Winkeljohn.  Triple-negative breast cancer. , 2008, Clinical journal of oncology nursing.

[3]  T. Andersson,et al.  The Wnt-5a–Derived Hexapeptide Foxy-5 Inhibits Breast Cancer Metastasis In vivo by Targeting Cell Motility , 2008, Clinical Cancer Research.

[4]  D. Loo,et al.  Antibody-based identification of cell surface antigens: targets for cancer therapy. , 2008, Current opinion in pharmacology.

[5]  C. Ford,et al.  Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells , 2008, Proceedings of the National Academy of Sciences.

[6]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[7]  Q. Rao,et al.  Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[8]  B. O’Malley,et al.  Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Bittner,et al.  The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition* , 2007, Journal of Biological Chemistry.

[10]  K. Riesbeck,et al.  Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells , 2006, Nucleic acids research.

[11]  W. Gerald,et al.  An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen , 2006, Oncogene.

[12]  N. Davidson,et al.  Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. , 2006, Cancer research.

[13]  B. Villoutreix,et al.  A Formylated Hexapeptide Ligand Mimics the Ability of Wnt-5a to Impair Migration of Human Breast Epithelial Cells* , 2006, Journal of Biological Chemistry.

[14]  M. Ueno,et al.  Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Katoh,et al.  WNT/PCP signaling pathway and human cancer (review). , 2005, Oncology reports.

[16]  T. Andersson,et al.  Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. , 2005, Cancer research.

[17]  M. Katoh,et al.  Comparative genomics on Wnt5a and Wnt5b genes. , 2005, International journal of molecular medicine.

[18]  G. Landberg,et al.  Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  R. Moon.  Teaching resource. Canonical Wnt/beta-catenin signaling. , 2004, Science's STKE : signal transduction knowledge environment.

[20]  Marcel Garcia,et al.  Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. , 2004, Critical reviews in oncology/hematology.

[21]  J. Cuzick.  Epidemiology of breast cancer--selected highlights. , 2003, Breast.

[22]  Philip M Murphy,et al.  Formyl-peptide receptors revisited. , 2002, Trends in immunology.

[23]  M. Bittner,et al.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.

[24]  P. Bendahl,et al.  Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. , 2002, Cancer research.

[25]  T. Andersson,et al.  Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. , 2001, Journal of cell science.

[26]  M. Kühl,et al.  Wnt signalling goes nuclear. , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  Laurie G. Smith,et al.  Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction , 1996, The Journal of cell biology.

[28]  S. Weitzman,et al.  Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  S. Baylin,et al.  Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.

[30]  A. Sonnenberg,et al.  Transfection of the int‐1 mammary oncogene in cuboidal RAC mammary cell line results in morphological transformation and tumorigenicity. , 1987, The EMBO journal.

[31]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[32]  A. Giordano,et al.  Epigenetic information and estrogen receptor alpha expression in breast cancer. , 2006, The oncologist.

[33]  Randall T Moon,et al.  Wnt and calcium signaling: beta-catenin-independent pathways. , 2005, Cell calcium.

[34]  J. Cuzick.  Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study). , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[35]  A. Ferguson,et al.  Regulation of estrogen receptor alpha function in breast cancer. , 1997, Critical reviews in oncogenesis.